John Elias
Minter EllisonThe equity capital markets team at Minter Ellison is led by Daniel Scotti (from Sydney) and James Hutton (from Melbourne); Scotti has extensive experience working with energy sector clients, while Hutton is the firm’s life sciences industry leader. The team supports clients through a range of equity and hybrid capital raisings, including IPOs, placements and share purchase plans. Sydney-based John Elias heads the debt capital markets and securitisation teams, specialising in structured finance and structured credit products for financial institutions and corporate clients alike.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
‘John Elias is outstanding. When explaining an issue or problem he will work through it and present solutions.'
'The team stands out for the skill set and reliability of the people.'
Key clients
- Mesoblast Limited
- PolyNovo Limited
- Accrue Therapeutics Pty Ltd
- Brandon Capital
- Aravax Pty Ltd
- Ginkgo Bioworks
- Medical Developments Limited
- BWX Limited
- Mayne Pharma Group Limited
- Cenntro Electric Group Limited
- Electro Optics Systems Holdings Limited
- Netlinkz Ltd
- Suncorp Corporate Services Pty Ltd
- Atrium Investment Management
- Challenger Life Company Limited
- Insight Investment and Aquasia
- Resi Wholesale Funding Pty Limited
- Nissan
Lawyers
Leading partners: Capital markets: debt
The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.
Leading partners: Capital markets: equity
The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.
Daniel Scotti
Minter EllisonPractice head
The lawyer(s) leading their teams.
Daniel Scotti, James Hutton, John Elias